|
Market Closed -
Euronext Bruxelles
11:55:00 2026-09-10 EDT
|
After hours 12:32:23 | |||
| 201.70 EUR | -1.42% |
|
201.35 | -0.17% |
| 10:55am | UCB: A rare window of affordability |  |
| 09-09 | UCB Receives U.S. FDA Breakthrough Therapy Designation For CIMZIA (Certolizumab Pegol) In Pregnant Women With Antiphospholipid Syndrome | CI |
Chart: Technical Analysis
Euronext BruxellesEUR
| Markets | Quality | ||
|---|---|---|---|
Euronext Bruxelles
| UCB | Real-time | |
CBOE
| UCB | Real-time | |
|
OTC Markets
| UCBJF | Delayed | |
|
London S.E.
| 0NZT | Delayed | |
|
Tradegate
| UNC | Real-time | |
|
Börse Stuttgart
| UNC | Delayed | |
|
Boerse Muenchen
| UNC | Real-time | |
|
Borsa Italiana
| 4UCB | End-of-day quote | |
|
Deutsche Boerse AG
| UNC | Delayed | |
|
CBOE
| 0NZT | Real-time | |
|
Wiener Boerse
| UCB | End-of-day quote | |
|
Xetra
| UNC | Delayed | |
OTC Markets
| UCBJY | Delayed | |
|
Deutsche Boerse AG
| UNC0 | Delayed | |
|
Börse Stuttgart
| UNC0 | Delayed |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 215.3 | 232.5 | 246 |
| Spread/Res. | -6.32% | -13.25% | -18.01% |
| Spread/Supp. | +0.25% | +4.78% | +6.58% |
| Support | 201.2 | 192.5 | 189.25 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- UCB Stock
- Charts UCB
Select your edition
All financial news and data tailored to specific country editions
